First longitudinal proton therapy study for children with craniopharyngioma
Follow-up to FLASH proton trial for bone cancer in extremities
Q&A with Fran Gregory, vice president of Emerging Therapies at Cardinal Health
The facility, with Hitachi gantry, is expected to open early next year
Insight from Stephanie Kriston, senior director of health policy, market access and reimbursement at Elekta
The latest in a string of lawsuits pressuring insurers to expand coverage
Will incorporate Pinnacle treatment planning into Elekta ONE software suite
Will create an interoperable, integrated workflow
Aimed at nuclear cardiology, general nuclear medicine, PET imaging
First clinical treatment with OXRAY system performed in Japan
Healthy cells tolerate treatment while tumors lose structure
A look around the industry at the latest technology entering the market